Filament Health Corp.

    Filament Health Corp.

    NNEO:FH
    - -
    CAD
    - -
    - -
    Filament Health Corp.
    NEO:FH
    (Cboe Canada)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2020
    2021
    2022
    2023
    2024
    TTM
    CAD
    - -
    - -
    - -
    0.01
    - -
    - -
    Revenue per Share
    - -
    -0.06
    -0.1
    -0.03
    -0.02
    -0.02
    Basic EPS, GAAP
    - -
    -0.04
    -0.02
    -0.02
    -0.01
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    0.1
    -0.01
    -0.02
    -0.02
    -0.02
    Book Value per Share
    - -
    0.04
    0.02
    0.01
    0.01
    - -
    Tangible Book Value per Share
    - -
    147
    170
    188
    237
    246
    Basic Weighted Avg Shares
    - -
    - -
    - -
    2
    1
    - -
    Sales/Revenue/Turnover
    - -
    - -
    -1,512.91
    -230.86
    -595.01
    -872.44
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    -9
    -16
    -5
    -5
    -5
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    -4,517.55
    -249.75
    -805.98
    -1,162.92
    Profit Margin (%)
    1
    5
    3
    1
    -1
    -2
    Working Capital
    - -
    1
    1
    1
    - -
    - -
    LT Debt
    1
    17
    3
    2
    2
    1
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    -123.73
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    256
    262
    262
    Market Capitalization
    9
    7
    6

    Working Capital

    CAD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    1
    1
    - -
    Cash, Cash Equivalents & STI
    1
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    2
    2
    Payables & Accruals
    1
    1
    2
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -29.87%
    Free Cash Flow
    - -
    - -
    -44.89%
    Net Income, GAAP
    - -
    - -
    -6.61%
    Sales/Revenue/Turnover
    - -
    - -
    -71.06%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    2
    2
    2024
    - -
    - -
    - -
    - -
    1
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.01
    -0.01
    -0.01
    - -
    -0.03
    2024
    - -
    - -
    - -
    - -
    -0.02
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business